Search Within

Jedd D Wolchok

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (108)
  2. Journal Article (84)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (195)
  2. GSK Faculty (195)
  3. Melanoma and Immunotherapeutics Service (195)
  4. Sloan Kettering Institute Postdocs (195)
  5. Solid Tumor Oncology Division (195)
  6. Sloan Kettering Institute Faculty (62)

More Groups

People
  1. Taha Merghoub (160)
  2. Sadna Budhu (69)
  3. Roberta Zappasodi (49)
  4. Cailian Liu (43)
  5. Daniel Hirschhorn Cymerman (41)
  6. Hong Zhong (28)

More People

Years
  1. 2023 (5)
  2. 2022 (29)
  3. 2021 (19)
  4. 2020 (20)
  5. 2019 (17)
  6. 2018 (29)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (42)
  2. Cancer Research (27)
  3. Journal of Immunology (12)
  4. Journal of Clinical Oncology (8)
  5. Journal of Investigative Dermatology (8)
  6. Nature (8)

More Publications

Publishers
  1. Biomed Central Ltd (43)
  2. American Association for Cancer Research (42)
  3. Nature Publishing Group (17)
  4. Cell Press (14)
  5. The American Association of Immunologists, Inc (12)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (195)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surgical stress promotes IL-6-driven tumor progression in ovarian cancer
    Meeting Abstract

    Praiss, A.; Longhini, A. L. F.; Pesci, G.; Green, H.; Ozsoy, M.; Kahn, R.; Brodeur, M.; Bhaloo, S.; Merghoub, T.; Wolchok, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of tumor metabolism on the microenvironment and response to immunotherapy
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Brunschvig, S.; Santhella, A.; Mane, M.; Vemuri, K.; Ijoma, J.; Kang, W.; Manovatodorova, K.; Koutcher, J.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
    Journal Article

    Pai, J. A.; Hellmann, M. D.; Sauter, J. L.; Mattar, M.; Rizvi, H.; Woo, H. J.; Shah, N.; Nguyen, E. M.; Uddin, F. Z.; Quintanal-Villalonga, A.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Signal-regulatory protein alpha (SIRPĪ±) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Lag3 blockade in combination with GITR improves anti-tumor immune responses in a preclinical melanoma model
    Meeting Abstract

    Maniyar, R.; Zappasodi, R.; Elhanati, Y.; St Jean, S.; Carrasco, S.; Greenbaum, B.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Apr-246 induces an increase in tumor immunogenicity in a p53 independent manner
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Lu, C.; Budhu, S.; George, M.; Ouerfelli, O.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save